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Enterococci have emerged in the past decade as an increas-
ingly important cause of nosocomial infections. Linezolid, the
first member of a new class of antibiotics (oxazolidinones),
has been introduced into clinical practice for infections
caused by multiresistant Gram-positive bacteria especially
vancomycin-resistant enterococci and methicillin-resistant
Staphylococcus aureus.1 However, linezolid resistant isolates
had emerged in several countries shortly after the drug
appeared on the market, and they have also emerged
recently in several hospitals in China.2 Vancomycin-resistant
enterococci have caused hospital outbreaks worldwide; the
occurrence of linezolid nonsusceptible enterococci, there-
fore, represents an immediate threat for patient care. A va-
riety of mutations in domain V of 23S rRNA genes, especially
G2576U and the multidrug resistance gene cfr, which codes
for an adenine methyltransferase that modifies adenosine at
position 2503 in the 23S rRNA, play an important role in
linezolid resistance of enterococci. Mutations of thebacterial
ribosomal proteins L3 and L4 have also been associated with
resistance to linezolid,3e5 and active efflux pump systems
may also be involved.6 Pulsed-field gel electrophoresis
(PFGE) has been considered the “gold standard” for the study
of hospital outbreaks because of its high degree of isolate
differentiation. Multilocus sequence typing (MLST) offers the
possibility to transfer typing data between laboratories or
compare results via Internet, thus providing a powerful tool
for global epidemiologic studies. The aim of this study was to
investigate the epidemiological and molecular characteris-
tics of linezolid nonsusceptible Enterococcus faecalis isolated
from a Chinese hospital.
Methods
Strain selection
Eight E. faecalis clinical strains exhibiting linezolid
Minimum inhibitory concentrations (MICs)  4 mg/L were
collected from the First Affiliated Hospital of Wenzhou
Medical University from January to July 2014. The clinical
records of patients with linezolid nonsusceptible E. faecalis
were examined retrospectively. Staphylococcus capitis-
(cfrþ) used for positive control in this study was donated by
Rong Zhang, charge technician from the Second Affiliated
Hospital of Zhejiang University.
Antimicrobial susceptibility testing
Susceptibility testing was determined using the agar dilu-
tion method and broth microdilution method (linezolid and
Daptomycin) according to Clinical and Laboratory Standards
Institute recommendations (CLSI, 2013). E. faecalis
ATCC29212 was used as quality control.
Molecular detection of mutations and resistance
gene cfr
The presence of mutations in domain V of 23S rRNA and
ribosomal proteins L3 and L4, and cfr gene wereinvestigated using polymerase chain reaction as described
previously.3,4 Genomic DNA extracted from E. faecalis
ATCC29212 and S. capitis-(cfrþ) were used as negative and
positive control for cfr, respectively. The positive poly-
merase chain reaction products were sequenced by
Shanghai Majorbio Bio-Pharm Technology Co. (Shanghai,
China). Nucleotide and deduced amino acid sequences
were compared with E. faecalis V583 strain and the line-
zolid susceptible E. faecalis clinical isolates (MIC, 1 mg/
mL) recovered from the same hospital during the study
interval.Effect of efflux pump mechanism
The MIC of linezolid was determined using the broth
microdilution method in either the presence or absence of
reserpine (20 mg/L) or carbonyl cyanide m-chlor-
ophenylhydrazone (CCCP; 5 mg/L), according to Clinical
and Laboratory Standards Institute guidelines. An inoculum
of 0.5 Mcfarland Standard of each isolate was inoculated
into MuellereHinton cation-adjusted broth containing serial
dilutions of linezolid. Four-fold or more reduction of line-
zolid MICs in the presence or the absence of reserpine or
CCCP was defined as a positive phenotype for efflux.7PFGE
PFGE was performed on the CHEFeMapper XA PFGE system
(Bio-Rad, Hercules, CA, USA) with a running time of 20
hours and pulse duration of 3.5e23.5 seconds. Salmonella
serotype Braenderup H9812 DNA marker was used for the
standard molecular weight and size determinations.
Pattern analysis was carried out using QualityOne software
(Bio-Rad Laboratories). Percentage similarities were iden-
tified on a dendrogram derived from the unweighted pair
group method with arithmetic averages. Band position
tolerance and optimization were set at 1.5% and 0.5%,
respectively. Isolates showing a similarity coefficient of
80% were considered to be genetically related.8MLST
The linezolid nonsusceptible E. faecalis isolates were
characterized by MLST using seven housekeeping genes
(gdh, gyd, pstS, gki, aroE, xpt, and yqiL) according to the
protocols and sequencing primers available at the E. fae-
calis database (http://efaecalis.mlst.net/).Results
Clinical characteristics of patients with linezolid
nonsusceptible E. faecalis
The clinical information of patients is given in Table 1. Two
of the strains were isolated from urine, three from vaginal
secretions, two from surgical wounds, and one from blood.
No patients were treated with linezolid before linezolid
nonsusceptible E. faecalis was isolated.
Table 1 Clinical characteristics of patients with linezolid nonsusceptible Enterococcus faecalis isolates
Patient No. Patient Admission Underlying disease Samples Previous
hospitalization
Treatment
outcome
LZD MIC
(mg/L)Age (y) Sex Ward Date
1(F465) 39 M GS 08/2/14 Colorectal cancer Wound No Discharge
on Day 32
4
2(F467) 50 M GAS 20/2/14 Acute pancreatitis Urine No Discharge
on Day 8
8
3(F471) 48 F GYN 12/2/14 Uterine leiomyoma Vaginal fluid No Discharge
on Day 15
4
4(F496) 33 F OP d None Vaginal fluid No d 8
5(F509) 42 M OP d Epididymitis Urine No d 8
6(F511) 80 M GS 21/7/14 Pancreatic cancer, OJ,
diabetes, hypertension
Blood Yes Relapse 8
7(F524) 31 F GYN 04/6/14 CIN, IUA Vaginal fluid Yes Discharge
on Day 10
8
8(F527) 82 F DER 04/5/14 T2DM, hypertension,
gout
Wound Yes Discharge
on Day 17
8
CIN Z cervical intraepithelial neoplasias; DER Z dermatology; F Z female; GAS Z gastroenterology; GS Z gastrointestinal surgery;
GYN Z gynecology; IUA Z intrauterine adhesion; LZD Z linezolid; M Z male; OJ Z obstructive jaundice; MIC = minimum inhibitory
concentration; OP Z outpatient; T2DM Z type 2 diabetes mellitus.
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The eight E. faecalis strains were resistant to linezolid at a
low level (4e8 mg/L), and all showed multidrug-resistant
phenotype (resistant to 3 different antibiotics). All (8/8)
of these isolates were resistant to quinupristin/dalfopris-
tin, tetracycline, and erythromycin, and high-level genta-
mycin and ciprofloxacin resistance were present in 87.5%
and 62.5% of these isolates, respectively. All E. faecalis
were susceptible to vancomycin, teicoplanin, daptomycin,
and the newly introduced tigecycline, and only one was
resistant to ampicillin, as shown in Table 2.
Resistance genes and mutations
Analysis of sequencing and blasted results failed to find
the cfr gene and the possible mutations, including domainTable 2 Antibiotic susceptibilities and linezolid resistance me
isolates
Patient
no.
MIC (mg/L)
AMP CIP F Q/D TET VAN ERY TGC TEC DAP
1(F465) 8 1 16 >4 16 2 8 0.12 2 0.5
2(F467) 8 16 16 >4 16 2 8 0.12 2 1
3(F471) 8 2 16 >4 16 1 8 0.12 2 1
4(F496) 8 16 64 >4 16 2 8 0.12 2 1
5(F509) 8 16 16 >4 16 2 8 0.12 2 1
6(F511) 16 16 16 >4 16 2 8 0.12 4 1
7(F524) 8 8 16 >4 16 1 8 0.12 2 0.5
8(F527) 8 1 16 >4 16 2 8 0.12 2 1
AMPZ ampicillin; CCCPZ carbonyl cyanide m-chlorophenylhydrazon
FZ nitrofurantoin; GEHZ high-level gentamycin; LZDZ linezolid; ML
field gel electrophoresis; Q/D Z quinupristin/dalfopristin; TEC
VAN Z vancomycin; MIC = minimum inhibitory concentration.V of the 23S rRNA genes, and the ribosomal proteins L3
and L4.
Effect of the efflux pump mechanism
The MICs of these isolates to linezolid were not changed or
just decreased at one dilution in the presence of CCCP or
reserpine. All strains grew in the presence of only reserpine
(20 mg/L) or CCCP (5 mg/L).
Molecular epidemiology analysis
PFGE analysis showed seven unrelated genotypes (Types
AeG). Type A contained two subtypes (A1, A2), and these
were isolated from patients in different wards. MLST data
showed that five sequence types (ST16, ST49, ST586, ST587,
and ST588) were assigned for these isolates, and the mostchanisms of linezolid nonsusceptible Enterococcus faecalis
Genetic
resistance
markers
PFGE
type
MLST
type
GEH LZD LZD þ
reserpine
LZD þ
CCCP
23S
rRNA
L3/L4 cfr
R 4 4 4  /  A1 ST16
R 8 4 8  /  B ST586
R 4 4 4  /  C ST587
R 8 4 8  /  D ST588
R 8 4 8  /  E ST16
R 8 4 8  /  F ST16
S 8 4 8  /  G ST49
R 8 4 8  /  A2 ST16
e; CIPZ ciprofloxacin; DAPZ daptomycin; ERYZ erythromycin;
STZ multilocus sequence typing; eZ negative; PFGEZ pulsed-
Z teicoplanin; TET Z tetracycline; TGC Z tigecycline;
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three novel sequence types detected from these isolates.
Isolates with differently related PFGE patterns (e.g., Type
A, Type E, and Type F) had the same sequence type (ST16;
Table 2). Patterns and dendrogram analysis produced by
PFGE are shown in Figure 1.
Discussion
According to an epidemiological survey carried out by
Chinese bacterial resistance monitoring network (CHINET)
in 2012, the resistance rate of E. faecalis to linezolid was
0.3%. This is the first report of linezolid nonsusceptible
Gram-positive bacteria in our hospital, and these strains
were all isolated in a short period, which is alarming and
requires ongoing surveillance. All isolates were multidrug
resistant, but still sensitive to glycopeptides. A retrospec-
tive analysis of the patients’ treatment history showed no
linezolid therapy prior to the linezolid nonsusceptible E.
faecalis isolation. These strains were isolated on widely
divergent dates and from different departments of the
hospital (Table1). The epidemiological investigation also
suggested that these isolates were sporadic cases, which
indicated that patient-to-patient transmission was not the
main cause of rapid emergence of linezolid resistance. It
could also have occurred on several independent occasions
and was often not related to linezolid administration. Ac-
cording to the clinical records, Patient 6 (F511), an 80-year-
old man suffering from various underlying diseases, has
been living in the hospital and been treated with various
antimicrobials except for linezolid for a long time (from July
2014 to present). We speculated that he carried the line-
zolid nonsusceptible isolates prior to his administration,
and selective pressure from long-term use of other anti-
microbials may have contributed to the occurrence of these
bacteria in the hospital setting.
Alterations in the 23S rRNA target have remained the
dominant mechanism detected among linezolid non-
susceptible enterococci, with a limited number of clinicalFigure 1. PFGE patterns and dendogram analysis of eight l
MZ Salmonella serotype Braenderup strain H9812 Marker (kb); lane
(Table 1). Dendogram was generated using QualityOne Software (B
was constructed using UPGMA clustering. A genetic similarity index
field gel electrophoresis; UPGMA Z unweighted pair group methodisolates also carrying cfr. However, our results did not show
any target site modifications or presence of cfr associated
with linezolid resistance. Recent studies evaluating the
linezolid resistance mechanisms in Gram-positive isolates
from Canada have also reported similar results.9,10
Multidrug resistance (MDR) efflux transporters that pump
out a wide range of substrates are known as one of the most
important mechanisms of antimicrobial resistance in E.
faecalis. The efflux pump phenotype experiment is based
on the fact that if efflux pump inhibitors (e.g., reserpine or
CCCP) significantly reduce the resistance of the MDR strain
to antibiotics to which it was initially resistant or renders
the MDR clinical strain as susceptible to antibiotics as the
wild-type strain, then it is highly probable that the MDR
phenotype of that strain is attributable to an over-
expression efflux pump system. However, in our study, the
MICs of the tested isolates to linezolid were not changed or
just decreased at one dilution in the presence of CCCP or
reserpine. It was likely that the capacity of the efflux pump
to eliminate linezolid was limited. Therefore, these low-
level resistance phenotypes were most probably due to
other mechanisms.
Overall, the present MLST results showed the existence of
five allelic profiles, of which ST586, ST587, and ST588 were
three novel sequence types. This indicates that some stim-
ulus may lead to the emergence of new characteristics of
regional strains. Isolates with differently related PFGE pat-
terns (e.g., Type A, Type E, and Type F) had the same
sequence type (ST16). However, they were isolated on
widely divergent dates and from different departments of
the hospital, and MLST is less discriminatory than PFGE when
a short timescale is examined. Therefore, these linezolid
nonsusceptible isolates represented sporadic cases.
In conclusion, we failed to detect the known possible
mechanisms of resistance to linezolid in these E. faecalis
strains. The epidemiological investigation indicated that
linezolid resistance possibly occurred on several indepen-
dent occasions and was often not related to linezolid
administration. A multidisciplinary approach is urgentlyinezolid-nonsusceptible Enterococcus faecalis isolates. Lane
s 1e8Z eight linezolid-nonsusceptible E. faecalis isolates 1e8
io-Rad Laboratories, Hercules, CA, USA). The phylogenetic tree
scale is shown in the left of the dendogram. PFGE Z pulsed-
with arithmetic mean.
Linezolid nonsusceptible E. faecalis isolates 599needed to evaluate the risk factors associated with the
rapid occurrence and dissemination of linezolid resistance.
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